持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/08/16 | 8,350 | 8,350 | 8,200 | 8,260 | -170 | -2% | 18,800 |
2018/08/15 | 8,540 | 8,540 | 8,390 | 8,430 | -60 | -0.7% | 13,000 |
2018/08/14 | 8,340 | 8,500 | 8,340 | 8,490 | +200 | +2.4% | 17,400 |
2018/08/13 | 8,370 | 8,410 | 8,280 | 8,290 | -230 | -2.7% | 18,600 |
2018/08/10 | 8,610 | 8,620 | 8,510 | 8,520 | -110 | -1.3% | 21,700 |
2018/08/09 | 8,330 | 8,750 | 8,260 | 8,630 | +310 | +3.7% | 45,200 |
2018/08/08 | 8,400 | 8,430 | 8,300 | 8,320 | -110 | -1.3% | 13,000 |
2018/08/07 | 8,390 | 8,430 | 8,290 | 8,430 | ±0 | ±0% | 16,400 |
2018/08/06 | 8,320 | 8,560 | 8,320 | 8,430 | +130 | +1.6% | 36,800 |
2018/08/03 | 7,840 | 8,300 | 7,840 | 8,300 | +310 | +3.9% | 48,300 |
2018/08/02 | 8,240 | 8,240 | 7,980 | 7,990 | -250 | -3% | 17,900 |
2018/08/01 | 8,300 | 8,320 | 8,180 | 8,240 | +150 | +1.9% | 31,800 |
2018/07/31 | 8,260 | 8,260 | 8,030 | 8,090 | -160 | -1.9% | 21,200 |
2018/07/30 | 8,350 | 8,350 | 8,230 | 8,250 | -150 | -1.8% | 12,200 |
2018/07/27 | 8,280 | 8,430 | 8,240 | 8,400 | +110 | +1.3% | 20,300 |
2018/07/26 | 8,150 | 8,290 | 8,080 | 8,290 | +230 | +2.9% | 20,300 |
2018/07/25 | 8,070 | 8,080 | 8,010 | 8,060 | -10 | -0.1% | 6,400 |
2018/07/24 | 8,180 | 8,180 | 8,040 | 8,070 | -20 | -0.2% | 9,800 |
2018/07/23 | 8,020 | 8,160 | 8,020 | 8,090 | +30 | +0.4% | 8,000 |
2018/07/20 | 8,060 | 8,170 | 8,040 | 8,060 | -60 | -0.7% | 12,900 |
2018/07/19 | 8,190 | 8,190 | 8,060 | 8,120 | -10 | -0.1% | 9,100 |
2018/07/18 | 8,190 | 8,190 | 8,070 | 8,130 | +50 | +0.6% | 8,600 |
2018/07/17 | 7,980 | 8,120 | 7,960 | 8,080 | +180 | +2.3% | 23,000 |
2018/07/13 | 7,800 | 7,940 | 7,800 | 7,900 | +120 | +1.5% | 10,200 |
2018/07/12 | 7,840 | 7,880 | 7,780 | 7,780 | ±0 | ±0% | 10,500 |
2018/07/11 | 7,850 | 7,850 | 7,730 | 7,780 | -100 | -1.3% | 13,100 |
2018/07/10 | 7,920 | 8,100 | 7,880 | 7,880 | -40 | -0.5% | 18,000 |
2018/07/09 | 7,840 | 7,980 | 7,790 | 7,920 | +80 | +1% | 16,600 |
2018/07/06 | 7,880 | 7,910 | 7,810 | 7,840 | +40 | +0.5% | 14,200 |
2018/07/05 | 7,890 | 7,930 | 7,760 | 7,800 | -120 | -1.5% | 9,600 |
2018/07/04 | 7,700 | 7,950 | 7,690 | 7,920 | +130 | +1.7% | 12,300 |
2018/07/03 | 7,810 | 7,850 | 7,720 | 7,790 | -50 | -0.6% | 20,000 |
2018/07/02 | 8,070 | 8,090 | 7,810 | 7,840 | -230 | -2.9% | 16,400 |
2018/06/29 | 8,100 | 8,140 | 7,860 | 8,070 | ±0 | ±0% | 19,400 |
2018/06/28 | 8,160 | 8,160 | 8,040 | 8,070 | -120 | -1.5% | 28,500 |
2018/06/27 | 8,200 | 8,250 | 8,160 | 8,190 | ±0 | ±0% | 13,600 |
2018/06/26 | 8,090 | 8,190 | 8,050 | 8,190 | +140 | +1.7% | 11,800 |
2018/06/25 | 8,190 | 8,190 | 8,020 | 8,050 | -150 | -1.8% | 11,000 |
2018/06/22 | 8,230 | 8,230 | 8,180 | 8,200 | +10 | +0.1% | 18,700 |
2018/06/21 | 8,050 | 8,260 | 8,050 | 8,190 | +40 | +0.5% | 17,200 |
2018/06/20 | 8,020 | 8,180 | 8,020 | 8,150 | +40 | +0.5% | 16,600 |
2018/06/19 | 8,190 | 8,190 | 8,090 | 8,110 | -20 | -0.2% | 10,400 |
2018/06/18 | 8,200 | 8,200 | 8,090 | 8,130 | -30 | -0.4% | 10,000 |
2018/06/15 | 8,190 | 8,260 | 8,130 | 8,160 | -110 | -1.3% | 25,800 |
2018/06/14 | 8,300 | 8,330 | 8,220 | 8,270 | -100 | -1.2% | 18,200 |
2018/06/13 | 8,200 | 8,430 | 8,170 | 8,370 | +210 | +2.6% | 26,900 |
2018/06/12 | 8,050 | 8,190 | 8,020 | 8,160 | +150 | +1.9% | 22,700 |
2018/06/11 | 7,980 | 8,040 | 7,940 | 8,010 | +110 | +1.4% | 7,300 |
2018/06/08 | 7,850 | 7,930 | 7,830 | 7,900 | -10 | -0.1% | 23,300 |
2018/06/07 | 7,870 | 7,950 | 7,790 | 7,910 | +100 | +1.3% | 13,800 |
1651~
1700
件表示中 / 3707件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 296,400円 | +5.1% | -7.0% | 2.70% | 19.46倍 | 0.80倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
東和薬品 | 308,000円 | +7.9% | -3.3% | 2.60% | 8.57倍 | 0.88倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 215,300円 | +3.1% | -6.5% | 2.23% | 9.99倍 | 1.06倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
杏林製薬 | 145,500円 | -2.4% | -52.3% | 3.92% | 17.41倍 | 0.61倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 201,100円 | +4.1% | -3.1% | 2.88% | 17.64倍 | 1.54倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム